Gluococorticoid could inXuence extracellular matrix synthesis through Sox9 via p38 MAPK pathway

Rheumatology International

Volumn 32, Issue 11, 2012, Pages 3669-3673

  Song, Yu Wen ^a   Zhang, Tao ^a   Wang, Wen Bo ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Chondrocytes; Collagen type II (Col II); Glucocorticoid; P38 MAPK; Sox9

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; DEXAMETHASONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR SOX9; GLUCOCORTICOID; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SOX9 PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; ENZYME INACTIVATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; KNEE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; SYNTHESIS; WESTERN BLOTTING; ARTICULAR CARTILAGE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; GENETICS; METABOLISM; MIDDLE AGED;

AGGRECANS; CARTILAGE, ARTICULAR; CELL SURVIVAL; CHONDROCYTES; COLLAGEN TYPE II; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KNEE JOINT; MALE; MIDDLE AGED; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR;

EID: 84872197194     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2091-8     Document Type: Article

References (19)

1. Bi W, Deng JM, Zhang Z et al (1999) Sox9 is required for cartilage formation. Nat Genet 22:85-89 (Pubitemid 29214811)
2. Huang W, Zhou X, Lefebvre V et al (2000) Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocytes-speciWc enhancer. Mol Cell Biol 20:4149-4158 (Pubitemid 30314512)
3. Shintani N, Hunziker EB (2007) Chondrogenic diVerentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transforming growth factor beta1 induce the formation of diVerent types of cartilaginous tissue. Arthr Rheum 56:1869-1879 (Pubitemid 47110386)
4. Sive JI, Baird P, Jeziorsk M et al (2002) Expression of chondrocyte markers by cells of normal and degenerated intervertebral discs. Mol Pathol 55:91-97 (Pubitemid 34293410)
5. Aigner T, Gebhard PM, Schmid E et al (2003) SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol 24:363-372 (Pubitemid 36993761)
6. Tchetina EV, Squires G, Poole AR (2005) Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte diVerentiation related genes in early human articular cartilage lesions. J Rheumatol 35:876-886 (Pubitemid 40676499)
7. Brew CJ, Clegg PD, Boot-Handford RP et al (2010) Gene expression in human chondrocytes in late OA is changed in both Wbrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy. Ann Rheum Dis 69:234-240
8. Cucchiarini M, Thurn T, Weimer A et al (2007) Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthr Rheum 29:158-167 (Pubitemid 46106188)
9. Sanchez C, Deberg MA, Piccardi N et al (2005) Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthr Cartil 13:988-997 (Pubitemid 41536131)
10. Paul R, Haydon RC, Cheng H et al (2003) Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 28:755-763 (Pubitemid 36459290)
11. Liu XY, Yang SH, Liang CY et al (2007) Construction of recombinant baculovirus Ac-CMV-hSox9 for gene therapy of intervertebral disc degeneration. Clin J Traumatol 22:94-100
12. Yoon ST, Kim K, Li J et al (2003) The eVect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine 28:1773-1780 (Pubitemid 37012751)
13. Li Y, Tew SR, Russell AM et al (2004) Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the eVects of enhanced expression of Sox9. Tissue Eng 10:575-584 (Pubitemid 38580278)
14. Majumdar MK, Chockalingam PS, Bhat RA et al (2008) Immortalized mouse articular cartilage cell lines retain chondrocyte phenotype and respond to both anabolic factor BMP-2 and proinXammatory factor IL-1. J Cell Physiol 215:68-76 (Pubitemid 351363192)
15. Bernard H, Jolelyne D (1987) EVects of dexamethasome on the growth of culture rabbit articular chondrocytes, relation with the nuclear glucocorticoid-recepter complex. Ann Rheum Dis 46:146-152
16. Roman-Blas JA, Stokes DG, Jimenez SA (2007) Modulation of TGF-beta signaling by proinXammatory cytokines in articular chondrocytes. Osteoarthr Cartil 15:1367-1377 (Pubitemid 350048557)
17. HoVman LM, Weston AD, Underhill TM (2003) Molecular mechanisms regulating chondroblast diVerentiation. J Bone Joint Surg (Am) 85:124-132 (Pubitemid 36535055)
18. Chandler GN, Wright V (1958) Deleterilous eVects of intra-Articullar hydrocortisone. Lancet 2:661-663
19. Nehrer S, Specttor M, Minas T (1999) Histologic analysis of tissue after failed cartilage repair procedures. J Clin Orthop 365:149-162 (Pubitemid 29382272)